Pharmaceutical companies differ from other types of companies
by Mr. Krishan Tiwari
Pharmaceutical companies differ from other companies due to their regulatory environment, nature of the products, and their business models such as;
Regulation-Intensive
- Pharmaceuticals are regulated by strict national and international regulations (such as the FDA in the United States and the EMA in Europe). Before drugs may be sold, they must pass stringent clinical testing and approval procedures.
Other industries: Whilst a few, like food and aviation industries, are subject to rules and regulations, as a whole, there is less inspection, particularly when it comes to consumer products and services.
- Expensive R&D and long-running drug development cycles: Just one drug’s development can cost billions of dollars and take ten to fifteen years. Trials for many medication candidates result in rejection.
Costs and development timeframes are typically lower in other industries. In some cases, it could take several years or months for a tech product to go from invention to market.
- Copyrights and Limited access Pharmaceuticals: Collect the costs of research and development mostly through patents. Generic goods may come into the market after a patent expires, which frequently results in a substantial decline in revenue.
Other industries: Although there are patents (such as in the computer sector), businesses frequently compete on the basis of functions, advertising, or layout rather than exclusive rights to patents.
- Pharmaceutical substance Sales and Marketing: Typically target healthcare professionals (B2B) rather than merely consumers (B2C). Evaluated research, medical conferences, and sales representatives are important.
Other industries: TV commercials, social media posts, and other forms of marketing tend to aim directly at customers.
- Scientific and Regulating Skill Pharmaceuticals: Need groups of regulatory specialists and expert scientists (chemists, biologists, pharmacologists).
Other companies might need creative or technical expertise, but they rarely need as many experts in advanced science and compliance.
